🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lijun Luo

Chinese Academy of Medical Sciences & Peking Union Medical College

ORCID: 0000-0002-2867-4782

Also affiliated with California University of Pennsylvania, University of Pennsylvania

Biochemistry, Genetics and Molecular BiologyMedicineEngineeringNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Phospholipase A 2 inhibitor-loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression”.

Phospholipase A 2 inhibitor-loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.15.426857

N/A

0DataRank · unranked

1 citations

Lesan Yan, Lijun Luo, Tao Gui, Ahmad Amirshaghaghi, Tianyan You +4 more

Superoxide dismutase-loaded porous polymersomes as highly efficient antioxidant nanoparticles targeting synovium for osteoarthritis therapy

Biomaterials(2022)10.1016/j.biomaterials.2022.121437

N/A

0DataRank · unranked

94 citations

Lijun Luo, Bonirath Chhay, Leilei Zhong, Yulong Wei, Lutian Yao +7 more

Varespladib-Based Lipid Nanoparticles as Highly Efficient Anti-Inflammatory Agents for Osteoarthritis Treatment

ACS Applied Materials & Interfaces(2025)10.1021/acsami.5c17533

N/A

0DataRank · unranked

1 citations

Tao Gui, Lijun Luo, Anatoliy V. Popov, Ritesh K. Isuri, Qi He +6 more